Bristol Myers Squibb
Carbon footprint
Primary Climate Goal
Bristol Myers Squibb aims to achieve carbon neutrality for Scope 1 + 2 by 2040
GHG emissions and Carbon intensity
Bristol Myers Squibb reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 371 Kt (+92/+33% y-o-y). Carbon intensity also increased to 8 t (+1.5/+23% y-o-y).
Bristol Myers Squibb's Scope 3 emissions surged to 1,890 Kt (
The company is committed to achieving carbon neutrality for Scope 1 + 2 by 2040, which translates into the estimated reduction of -20 Kt per annum over the period of FY2022 - FY2040. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.
Bristol Myers Squibb aims to achive carbon neutrality across its operations (Scope 1 + 2) in 2040. Companies normally become carbon neutral with the help of the acquisition of carbon offsets rather than absolute reductions in their own greenhouse emissions. Also, carbon neutrality does not include non-CO2 GHG emissions.